Journal
MOLECULAR NEUROBIOLOGY
Volume 58, Issue 12, Pages 6335-6349Publisher
SPRINGER
DOI: 10.1007/s12035-021-02544-1
Keywords
Alzheimer's disease; Cancer; Risk factors; Inflammation; Signaling pathways; Infection agents; Therapy
Categories
Ask authors/readers for more resources
The negative association between Alzheimer's disease and cancer suggests that susceptibility to one disease may protect against the other. Understanding the biological mechanisms of AD and cancer, as well as their relationship, could lead to overcoming the unsolved problems of both diseases affecting the growing human population.
The negative association between Alzheimer's disease (AD) and cancer suggests that susceptibility to one disease may protect against the other. When biological mechanisms of AD and cancer and relationship between them are understood, the unsolved problem of both diseases which still touches the growing human population could be overcome. Actual information about biological mechanisms and common risk factors such as chronic inflammation, age-related metabolic deregulation, and family history is presented here. Common signaling pathways, e.g., p53, Wnt, role of Pin1, and microRNA, are discussed as well. Much attention is also paid to the potential impact of chronic viral, bacterial, and fungal infections that are responsible for the inflammatory pathway in AD and also play a key role to cancer development. New data about common mechanisms in etiopathology of cancer and neurological diseases suggests new therapeutic strategies. Among them, the use of nilotinib, tyrosine kinase inhibitor, protein kinase C, and bexarotene is the most promising.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available